Illumina's Bid For $25M Over DNA Tech Patents Goes To Jury
Attorneys for Illumina urged a California federal jury during closing arguments Monday to find that its Chinese rival BGI Genomics and its subsidiaries owe $25.4 million for willfully infringing Illumina patents...To view the full article, register now.
Already a subscriber? Click here to view full article